Physician
General Surgery
Dr. Mohammad R. Salabat, MD
|
|
Give Review
Dr. Mohammad R. Salabat is an expert in the field of General Surgery. Mohammad R. Salabat has written publications. He has 17 publications published with PubMed. The lastest publication is: 'Durability of De Vega Tricuspid Valve Annuloplasty for Severe Tricuspid Regurgitation During Left Ventricular Assist Device Implantation.'
Publications
- Durability of De Vega Tricuspid Valve Annuloplasty for Severe Tricuspid Regurgitation During Left Ventricular Assist Device Implantation.
- Apigenin Down-Regulates the Hypoxia Response Genes: HIF-1α, GLUT-1, and VEGF in Human Pancreatic Cancer Cells.
- A high omega-3 fatty acid diet mitigates murine pancreatic precancer development.
- Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.
- The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells.
- Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines.
- Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
- Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
- Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
- On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
- Identification and in silico characterization of a novel gene: TPA induced trans-membrane protein.
- Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?
- Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest.
- Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.
- A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest.
- Sansalvamide induces pancreatic cancer growth arrest through changes in the cell cycle.
Doctors Specialties
- Emergency Medicine
- General Surgery
Accepted Insurances
Education
-
University of Chicago -
Loyola University
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan Lippitz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Harlan, MD |
|
Dr. Carlos Ortega, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott French, MD |
|
|
Dr. Elliot S. Bishop, MD |
|
|
Dr. Theodore K. Koutouzis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian T. Welch, MD |
|
|
Dr. Jayakrishna V. Pandit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jeremy B. Kraff |
|
|
Dr. Hector Aguilera, MD
This Doctor is OpenDoctor Recommended.
|